ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation.
- Resource Type
- Article
- Source
- Journal of Cellular Biochemistry; Feb2019, Vol. 120 Issue 2, p1386-1397, 12p
- Subject
- Language
- ISSN
- 07302312